Trial Scorecard: REDEFINE 1 and 2 US$ 26.64 Min. order: 1 piece ★★★★★ 4.7 (82 reviews) Sold : Login>>
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants - Gabe - 2024 - Diabetes, Obesity and Metabolism US$ 26.64 Min. order: 1 piece ★★★★★ 4.8 (35 reviews) Sold : Login>>
CagriSema: The New GLP 1 and Amylin Combination That May Transform Obesity Treatment US$ 21.06 Min. order: 1 piece ★★★★★ 4.0 (34 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 25.72 Min. order: 1 piece ★★★★★ 4.5 (234 reviews) Sold : Login>>
GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction US$ 27.50 Min. order: 1 piece ★★★★★ 4.2 (267 reviews) Sold : Login>>